News
Novavax COVID-19 Vaccine Granted Fast Track Designation by U.S. FDA
Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced that the U.S. FDA has granted Fast Track Designation for...
News
Llama nanobodies could be a powerful weapon against COVID-19
The researchers at the University of Pittsburgh School of Medicine describe a new method to extract tiny but extremely powerful SARS-CoV-2 antibody fragments from...
Drug Research
Oxford Biomedica and PhoreMost enter gene therapy discovery collaboration
Oxford Biomedica plc , a leading gene and cell therapy group and PhoreMost Limited, the UK-based biopharmaceutical company dedicated to developing drugs against intractable...
Clinical Trials
Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study
Pfizer Inc. and BioNTech SE announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against COVID-19 in participants without prior...
Drug Research
Thermo Fisher Scientific and Innoforce Partner to Establish Biologics and Steriles Drug Manufacturing Facility in China
Thermo Fisher Scientific Inc., the world leader in serving science, and Innoforce, a bioinnovation-enabling company, announced they have signed a joint venture agreement to...
News
CDMOs benefit from COVID-19 impacts but mega-cap pharma innovation slowing outsourcing according to CPhI Annual Report
The global contact services sector is benefiting from a switch towards COVID-19 manufacturing (vaccine and therapy) and clinical stage contracts, but mega-cap innovator drug...
Clinical Trials
Pfizer Announces Positive Phase 3 Study Results for XELJANZ in Ankylosing Spondylitis
Pfizer Inc. announced positive results from a Phase 3 investigational study evaluating the safety and efficacy of tofacitinib in adults with active ankylosing spondylitis...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read